Filing Flows › AbbVie (ABBV) › Q2 2025
AbbVie (ABBV) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 4, 2025
AbbVie (ABBV) reported revenue of $15.4B for the second quarter 2025 (Q2 2025), +7% from a year earlier and +16% from the quarter before. Operating margin was 31.7%, net earnings $941M (6.1% of revenue).
AbbVie, Q2 2025: revenue $15.4B (+7% year over year), operating margin 31.7%, net earnings $941M, operating cash flow $5.2B. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.4B | +16% | +7% |
| Operating profit | $4.9B | +31% | +22% |
| Net earnings | $941M | -27% | -31% |
| Operating cash flow | $5.2B | +215% | +127% |
| Free cash flow | $4.9B | +249% | +141% |
What changed
Revenue was $15.4B in Q2 2025, up 7% year over year and up 16% from the previous quarter.
Operating profit was $4.9B, a 31.7% margin (up 4.1 points year over year). Of the extra revenue versus a year earlier, 93% reached operating profit, above the 28% margin then. Total costs grew 1% against revenue growth of 7%. Net earnings were $0.94B, down 32% year over year. The effective tax rate was 39.4%.
Operating cash flow was $5.2B (up 127% year over year), 548% of net earnings. Non-cash charges added back $2.1B of depreciation and amortization and $0.18B of share-based compensation. Working capital and other items added $1.9B. Capital expenditures of $0.27B left free cash flow of $4.9B.
Questions
What was AbbVie's revenue in the second quarter 2025?
AbbVie (ABBV) reported revenue of $15.4B for the second quarter 2025 (Q2 2025), +7% from a year earlier and +16% from the quarter before.
Was AbbVie profitable in the second quarter 2025?
Operating profit was $4.9B (31.7% of revenue) and net earnings $941M.
Source: AbbVie 10-Q on SEC EDGAR.